Loan Receivable |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||
| Loan Receivable [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||
| Loan Receivable | 8. Loan Receivable
On February 9, 2026, the Company entered into a Loan Agreement with Curiosum Ltd., a private corporation (“Curiosum” or the “Borrower”), pursuant to which the Company advanced a loan of $251,110 to Curiosum (the “Loan”). The Loan was advanced on February 9, 2026.
The Loan arose directly from the settlement agreement dated February 9, 2026 between the Company and KAOS Capital Ltd. (the “KAOS Settlement”). Under the KAOS Settlement, the Borrower agreed to purchase 50,220 common shares of PBM held by the KAOS Group at US$5.00 per share, for a total purchase price of $251,110 (See Note 16). The Loan proceeds were directed to fund this share repurchase.
Subsequent to year end, the Loan was repaid in full. |
|||||||||||||||||||||||||||||||||||||||||||||